Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 1.02 MB, PDF document

  • Katharina Nimptsch
  • Krasimira Aleksandrova
  • Thu Thi Pham
  • Nikos Papadimitriou
  • Jürgen Janke
  • Sofia Christakoudi
  • Alicia Heath
  • Anja Olsen
  • Matthias B Schulze
  • Verena Katzke
  • Rudolf Kaaks
  • Bethany van Guelpen
  • Justin Harbs
  • Domenico Palli
  • Alessandra Macciotta
  • Fabrizio Pasanisi
  • Sandra Milena Colorado Yohar
  • Marcela Guevara
  • Pilar Amiano
  • Sara Grioni
  • Paula Gabriela Jakszyn
  • Jane C Figueiredo
  • N Jewel Samadder
  • Christopher I Li
  • Victor Moreno
  • John D Potter
  • Robert E Schoen
  • Caroline Y Um
  • Elisabete Weiderpass
  • Mazda Jenab
  • Marc J Gunter
  • Tobias Pischon

BACKGROUND: Fatty acid binding protein 4 (FABP-4) is a lipid-binding adipokine upregulated in obesity, which may facilitate fatty acid supply for tumor growth and promote insulin resistance and inflammation and may thus play a role in colorectal cancer (CRC) development. We aimed to investigate the association between circulating FABP-4 and CRC and to assess potential causality using a Mendelian randomization (MR) approach.

METHODS: The association between pre-diagnostic plasma measurements of FABP-4 and CRC risk was investigated in a nested case-control study in 1324 CRC cases and the same number of matched controls within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A two-sample Mendelian randomization study was conducted based on three genetic variants (1 cis, 2 trans) associated with circulating FABP-4 identified in a published genome-wide association study (discovery n = 20,436) and data from 58,131 CRC cases and 67,347 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry.

RESULTS: In conditional logistic regression models adjusted for potential confounders including body size, the estimated relative risk, RR (95% confidence interval, CI) per one standard deviation, SD (8.9 ng/mL) higher FABP-4 concentration was 1.01 (0.92, 1.12) overall, 0.95 (0.80, 1.13) in men and 1.09 (0.95, 1.25) in women. Genetically determined higher FABP-4 was not associated with colorectal cancer risk (RR per FABP-4 SD was 1.10 (0.95, 1.27) overall, 1.03 (0.84, 1.26) in men and 1.21 (0.98, 1.48) in women). However, in a cis-MR approach, a statistically significant association was observed in women (RR 1.56, 1.09, 2.23) but not overall (RR 1.23, 0.97, 1.57) or in men (0.99, 0.71, 1.37).

CONCLUSIONS: Taken together, these analyses provide no support for a causal role of circulating FABP-4 in the development of CRC, although the cis-MR provides some evidence for a positive association in women, which may deserve to be investigated further.

Original languageEnglish
Article number391
JournalBMC Medicine
Volume21
Issue number1
Number of pages16
ISSN1741-7015
DOIs
Publication statusPublished - 2023

Bibliographical note

© 2023. BioMed Central Ltd., part of Springer Nature.

    Research areas

  • Female, Humans, Male, Case-Control Studies, Colorectal Neoplasms/epidemiology, Genome-Wide Association Study, Mendelian Randomization Analysis, Polymorphism, Single Nucleotide/genetics, Prospective Studies, Risk Factors

ID: 372682470